Bristol-Myers Squibb Company
NYSESnapshot as of 7 May 2026
Bristol-Myers Squibb reports Q1 2026 results on May 5 with the stock down 4% on the month and short sellers quietly building pressure into the event. Short interest has climbed sharply over the past week — up more than…
Bristol-Myers Squibb heads into its April 30 Q1 earnings call with an unusual combination — short sellers are quietly rebuilding positions, options traders are leaning more optimistic than usual, and the Street holds a…
Market Overview Price: $59.39 (as of April 21, 2026) Market Cap: $121.3B Sector: Pharmaceuticals Exchange: NYSE Recent Performance 1-day change: +0.44% 1-week change: +2.26% 1-month change: +3.32% YTD:…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BMY — free to start on ORTEX.
Sign up for free →Open BMY on ORTEX